trent
hcv
studi
mortal
rate
ethnic
differ
outcom
wl
irv
earli
evolut
hepat
c
viru
hcv
quasispeci
liver
transplant
f
stolikel
impact
target
vaccin
hbv
genotyp
amsterdam
bruisten
human
cytomegalovirusspecif
tcell
organ
transplant
recipi
lilleri
monitor
cytomegaloviru
adenoviru
infect
differ
condit
regimen
acm
kroe
outcom
reactiv
haematopoiet
cell
transplant
children
rj
de
pagter
